AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $27,000 | +92.9% | 4,000 | -24.5% | 0.00% | – |
Q4 2018 | $14,000 | -39.1% | 5,300 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $23,000 | -28.1% | 5,300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $32,000 | -17.9% | 5,300 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $39,000 | +77.3% | 5,300 | +100.0% | 0.00% | 0.0% |
Q4 2017 | $22,000 | -43.6% | 2,650 | -33.8% | 0.00% | 0.0% |
Q1 2017 | $39,000 | – | 4,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |